In a review of clinical studies on the efficacy of resveratrol on hyperglycemic status in type 2 diabetic patients, Movahed et al. showed that an oral dose of resveratrol of 1 g per day for 45 days significantly decreased fasting blood glucose, insulin, and systolic blood pressure from 175.7 mg/dL, 10.2 μ international unit (IU)/mL, and 129 mmHg to 140.1 mg/dL, 5.4 μIU/mL, and 121.5 mmHg, respectively [78]. The gene discussed is INS; the disease is type 2 diabetes mellitus.